FRANK KARBE - 10 Apr 2023 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Chief Executive Officer, President, Treasurer and Secretary, Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Issuer symbol
BTTX on OTC
Transactions as of
10 Apr 2023
Net transactions value
+$200,000
Form type
4
Filing time
12 Apr 2023, 16:15:14 UTC
Previous filing
15 Sep 2022
Next filing
30 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $200,000 +242,424 +485% $0.8250 292,424 10 Apr 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 242,424 shares of Issuer common stock on April 10, 2023 for $0.825 per share.

Remarks:

Chief Executive Officer, President, Treasurer and Secretary